Medicare Enrolled

Dr. Barthelemy Liabaud, M.D.

Interventional Pain Medicine Physician · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
860 5TH AVE, New York, NY 10065
3479317239
In practice since 2016 (10 years)
NPI: 1235592239 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liabaud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liabaud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liabaud

Dr. Barthelemy Liabaud is an interventional pain medicine physician in New York, NY, with 10 years of NPI registration. Based on federal Medicare data, Dr. Liabaud performed 7,101 Medicare services across 843 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liabaud received a total of $18,678 from 21 pharmaceutical and/or device companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liabaud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 21% volume in NY $18,678 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,101
Medicare services
Top 21% in NY for interventional pain medicine physician
843
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~710 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
5,365 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
541 $114 $400
Contrast dye for imaging, lower concentration 406 $0 $5
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
97 $237 $1,804
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
97 $121 $1,248
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $79 $350
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
65 $3 $20
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
51 $241 $1,000
Drug test, instrument-assisted
A laboratory test to detect the presence of drugs using an instrument for observation.
50 $17 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
49 $149 $450
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
43 $195 $800
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
42 $111 $750
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
40 $65 $900
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
40 $191 $800
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
27 $245 $1,333
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
27 $124 $972
Electronic analysis of implanted neurostimulator with complex programming
This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators.
24 $53 $800
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
22 $623 $1,250
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
21 $333 $1,048
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
18 $243 $1,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,678
Total received (2021-2024)
Avg $4,670/year across 4 years
Top 15% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
147
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,678 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,358
2023
$7,974
2022
$5,588
2021
$759

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Saluda Medical Americas, Inc.
$2,165
Abbott Laboratories
$798
Boston Scientific Corporation
$404
PAINTEQ LLC
$335
Clariance SAS
$257
Nalu Medical, Inc.
$163
PFIZER INC.
$82
Spinal Simplicity, LLC
$57
DePuy Synthes Sales Inc.
$50
Forte Bio-Pharma LLC
$27
Nevro Corp.
$20
Top 3 companies account for 77.3% of 2024 payments
All-time payments by company (2021-2024) ›
Abbott Laboratories
$12,745
Saluda Medical Americas, Inc.
$2,184
Boston Scientific Corporation
$747
Medtronic, Inc.
$674
Nalu Medical, Inc.
$361
PAINTEQ LLC
$335
Clariance SAS
$257
MML US, Inc.
$240
BOSTON SCIENTIFIC CORPORATION
$201
Vertos Medical, Inc.
$155
Nevro Corp.
$145
Spinal Simplicity, LLC
$140
PFIZER INC.
$135
Spineart USA Inc
$117
Stryker Corporation
$55
DePuy Synthes Sales Inc.
$50
Kowa Pharmaceuticals America, Inc.
$44
SPR Therapeutics, Inc
$32
Forte Bio-Pharma LLC
$27
Collegium Pharmaceutical, Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 83.9% of all-time payments
Associated products mentioned in payments ›
COMIRNATY · ETERNA · EVEREST SPINAL SYSTEM · Evoke · Evoke SCS · HA MINUTEMAN G3-R · INFINITY · INTELLIS · INTELLIS ADAPTIVESTIM · NALOCET · NURTEC ODT · Nalu Neurostimulation System · ORTHOVISC · PAINTEQ · PERLA TL · PROCLAIM · PRODIGY · Penta SCS Leads · Proclaim IPG · Protege Family of SCS IPGs · RELISTOR · RESTORE · ReActiv8 · SEGLENTIS · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an interventional pain medicine physician in New York?
Compare interventional pain medicine physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional pain medicine physicians within 10 mi
91
Per 100K population
5.6
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liabaud is a mixed practice specialist, with above-average Medicare volume (top 21% in NY), with low-engagement industry engagement in the top 15% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liabaud experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Liabaud performed 5,365 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liabaud receive payments from pharmaceutical companies?
Yes. Dr. Liabaud received a total of $18,678 from 21 companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liabaud's costs compare to other interventional pain medicine physicians in New York?
Dr. Liabaud's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liabaud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →